Bunce C Correlation, agreement, and Bland-Altman analysis: statistical analysis of method comparison studies. Am J Ophthalmol. 2009 Jul;148(1):4-6. doi: 10.1016/j.ajo.2008.09.032.
Chen JH, Waite L, Kurina LM, Thisted RA, McClintock M, Lauderdale DS Insomnia symptoms and actigraph-estimated sleep characteristics in a nationally representative sample of older adults. J Gerontol A Biol Sci Med Sci. 2015 Feb;70(2):185-92. doi: 10.1093/gerona/glu144. Epub 2014 Sep 8.
Danzig R, Wang M, Shah A, Trotti LM The wrist is not the brain: Estimation of sleep by clinical and consumer wearable actigraphy devices is impacted by multiple patient- and device-specific factors. J Sleep Res. 2020 Feb;29(1):e12926. doi: 10.1111/jsr.12926. Epub 2019 Oct 17.
Gordt K, Gerhardy T, Najafi B, Schwenk M Effects of Wearable Sensor-Based Balance and Gait Training on Balance, Gait, and Functional Performance in Healthy and Patient Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Gerontology. 2018;64(1):74-89. doi: 10.1159/000481454. Epub 2017 Nov 1. Review.
Kahawage P, Jumabhoy R, Hamill K, de Zambotti M, Drummond SPA Validity, potential clinical utility, and comparison of consumer and research-grade activity trackers in Insomnia Disorder I: In-lab validation against polysomnography. J Sleep Res. 2020 Feb;29(1):e12931. doi: 10.1111/jsr.12931. Epub 2019 Oct 18.
Koffel E, McCurry SM, Smith MT, Vitiello MV Improving pain and sleep in middle-aged and older adults: the promise of behavioral sleep interventions. Pain. 2019 Mar;160(3):529-534. doi: 10.1097/j.pain.0000000000001423. Review.
Kubala AG, Barone Gibbs B, Buysse DJ, Patel SR, Hall MH, Kline CE Field-based Measurement of Sleep: Agreement between Six Commercial Activity Monitors and a Validated Accelerometer. Behav Sleep Med. 2020 Sep-Oct;18(5):637-652. doi: 10.1080/15402002.2019.1651316. Epub 2019 Aug 27.
Lee JM, Kim Y, Welk GJ Validity of consumer-based physical activity monitors. Med Sci Sports Exerc. 2014 Sep;46(9):1840-8. doi: 10.1249/MSS.0000000000000287.
Lee PH, Suen LK The convergent validity of Actiwatch 2 and ActiGraph Link accelerometers in measuring total sleeping period, wake after sleep onset, and sleep efficiency in free-living condition. Sleep Breath. 2017 Mar;21(1):209-215. doi: 10.1007/s11325-016-1406-0. Epub 2016 Sep 10.
Merilahti J, Korhonen I Association between Continuous Wearable Activity Monitoring and Self-Reported Functioning in Assisted Living Facility and Nursing Home Residents. J Frailty Aging. 2016;5(4):225-232.
Peake JM, Kerr G, Sullivan JP A Critical Review of Consumer Wearables, Mobile Applications, and Equipment for Providing Biofeedback, Monitoring Stress, and Sleep in Physically Active Populations. Front Physiol. 2018 Jun 28;9:743. doi: 10.3389/fphys.2018.00743. eCollection 2018. Review.
Shelgikar AV, Anderson PF, Stephens MR Sleep Tracking, Wearable Technology, and Opportunities for Research and Clinical Care. Chest. 2016 Sep;150(3):732-43. doi: 10.1016/j.chest.2016.04.016. Epub 2016 Apr 29. Review.
Smith MT, McCrae CS, Cheung J, Martin JL, Harrod CG, Heald JL, Carden KA Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2018 Jul 15;14(7):1231-1237. doi: 10.5664/jcsm.7230.
Tilmanne J, Urbain J, Kothare MV, Wouwer AV, Kothare SV Algorithms for sleep-wake identification using actigraphy: a comparative study and new results. J Sleep Res. 2009 Mar;18(1):85-98. doi: 10.1111/j.1365-2869.2008.00706.x.
Wade AG The societal costs of insomnia. Neuropsychiatr Dis Treat. 2010 Dec 20;7:1-18. doi: 10.2147/NDT.S15123.
Xie J, Wen D, Liang L, Jia Y, Gao L, Lei J Evaluating the Validity of Current Mainstream Wearable Devices in Fitness Tracking Under Various Physical Activities: Comparative Study. JMIR Mhealth Uhealth. 2018 Apr 12;6(4):e94. doi: 10.2196/mhealth.9754.
Validation of the Quality of Sleep Data for Xiaomi Domestic Wristbands
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
